Aromatase inhibitor maintenance therapy in high grade advanced ovarian cancer to delay first...

B Radl, B Mlineritsch - memo-Magazine of European Medical Oncology, 2017 - Springer

ASCO 2017—highlights of gynecological cancer | memo - Magazine of European Medical
Oncology Skip to main content SpringerLink Log in Menu Find a journal Publish with us …

被引用次数：6 相关文章所有 8 个版本

[PDF] koreamed.org

[PDF][PDF] Highlights from the gynecologic oncology track at the 2017 Annual Meeting of the American Society of Clinical Oncology

JE Wolford, KS Tewari - Journal of gynecologic oncology, 2017 - synapse.koreamed.org

The American Society of Clinical Oncology (ASCO) 2017 Annual Meeting was held again at
the McCormick Convention Center in Chicago, IL, USA. Over 37,500 international …

被引用次数：6 相关文章所有 19 个版本

[PDF] tandfonline.com

Systematic literature review of efficacy and safety of first-line maintenance therapy trials in advanced ovarian cancer

H Guy, C Hawkes, L Walder, IA Malinowska… - Future …, 2022 - Taylor & Francis

Aim: To review safety and efficacy outcomes in studies of first-line maintenance therapies for
advanced ovarian cancer. Methods: A systematic literature review was performed (27 …

被引用次数：1 相关文章所有 3 个版本

[HTML] nih.gov

A Prospective Study on Metronomic Scheduling of Non-chemotherapeutic Drugs in Advanced Epithelial Ovarian Cancers

S Shivdas, T Rajatharangani, PS Rathod… - Indian Journal of …, 2021 - Springer

The objectives of this study are to assess the role of non-chemotherapeutic combination of
drugs as maintenance therapy, after standard treatment, for advanced epithelial ovarian …

Standard changing news der Senologie und der Gynäkologischen Onkologie 2018

C Preuß, F Heindl, SM Jud, A Hein, CC Hack… - Der …, 2018 - thieme-connect.com

Im Bereich der gynäkologischen Onkologie und Senologie gab es auch in diesem Jahr
zahlreiche Publikationen und Kongressbeiträge, die Änderungen oder Ergänzungen zu …